Current contraceptive research and development.
The approval of various new contraceptive products in recent years has resulted in broadening the options available to women. Trends in contraceptive research for hormonal products include variations in dose and dosing regimens, introduction of novel compounds, evaluation of products for noncontraceptive indications, and development of nonoral delivery systems and male contraceptives. Nonhormonal areas of research include microbicidal products, dual protection methods, and contraceptive vaccines. For each of these categories, contraceptive products currently in development and the potential implications for adolescents are discussed. Ongoing contraceptive research and development activity is robust and should ensure the continued availability of various new products for adolescents.
Reape
Kathleen Z
KZ
Clinical Operations, Duramed Research, Inc., a subsidiary of Barr Pharmaceuticals, Inc., One Belmont Avenue, Suite 1100, Bala Cynwyd, PA 19004, USA. kreape@barrlabs.com
D000293:Adolescent; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry*; D004333:Drug Administration Routes; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D005260:Female; D006801:Humans; D011247:Pregnancy; D011253:Pregnancy in Adolescence / Q000517:prevention & control* / Q000706:statistics & numerical data; D012106:Research
D003276:Contraceptives, Oral